No abstract available


This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Roeker, L., Eyre, T., Thompson, M., Lamanna, N., Coltoff, A., Davids, M., Baker, P., Leslie, L., Rogers, K., Allan, J., Cordoba, R., Lopez-Garcia, A., Antic, D., Pagel, J., Martinez-Calle, N., Garcia-Marco, J., Hernández-Rivas, J., Miras, F., Coombs, C., Österborg, A., Seddon, A., López-Jiménez, J., Wilson, M., El-Sharkawi, D., Wojenski, D., Ma, S., Munir, T., Valenciano, S., Seymour, E., Barr, P., Pu, J., Patten, P., Perini, G., Huntington, S., Parry, H., Sundaram, S., Skarbnik, A., Kamdar, M., Jacobs, R., Walter, H., Walewska, R., Broom, A., Lebowitz, S., Isaac, K., Portell, C., Ahn, I., Ujjani, C., Shadman, M., Skånland, S., Chong, E. & Mato, A. 2021, 'COVID-19 in patients with CLL: improved survival outcomes and update on management strategies', Blood. https://doi.org/10.1182/blood.2021011841

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 17 June 2022
Was this page helpful?